Page 7 - Deepak Bhatt News Today

KATHMANDU, April 22: Himalayan Stock Exchange (HSX) has applied to the Securities Board of Nepal (SEBON) for a new stock exchange license.

From a novel topical gene therapy to a multi-pathway targeting HF drug, the second quarter of 2023 is laden with interesting regulatory decisions.

Dr Bhatt, a cardiologist at Mount Sinai in New York, said the best advice in terms of a heart healthy diet, is a diet that is relatively low in calories.

Blood pressure readings can vary widely between doctor's visits, according to new research published in March in the journal Circulation: Cardiovascular Quality and Outcomes. The findings further suggest that supplemental home monitoring of blood pressure may be helpful for certain people.

New study finds no effect on atrial contractions though there may be other health impacts

But the study was marred by a large placebo effect and adherence issues, and so development of baxdrostat is continuing, researchers say.

Trialists believe the results, at odds with the positive BrigHTN trial, stem from unexpected benefits in placebo-treated patients.

In a new study, most elite athletes with a diagnosed genetic heart disease did not experience serious or fatal symptoms of their condition, such as sudden cardiac death. The research

Six-month data had hinted at less efficacy in this subgroup, but just as in the main trial, longer follow-up boosted outcomes.

THURSDAY, Feb. 9, 2023 (HealthDay News) -- Using a "neuroprotectant" drug alongside the standard surgical removal of a clot may slash the risk of death and disability following a stroke,